GSK plc
GSK
$40.32
$0.270.67%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.42B | 4.31B | 3.77B | 5.17B | 7.25B |
| Total Receivables | 8.23B | 10.54B | 9.83B | 9.21B | 8.91B |
| Inventory | 7.10B | 7.93B | 7.40B | 7.20B | 7.00B |
| Prepaid Expenses | 488.25M | -- | -- | -- | 452.18M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 46.32M | 403.43M | 181.99M | 147.77M | 137.57M |
| Total Current Assets | 21.28B | 23.18B | 21.19B | 21.73B | 23.75B |
|
|
|||||
| Total Current Assets | 21.28B | 23.18B | 21.19B | 21.73B | 23.75B |
| Net Property, Plant & Equipment | 12.61B | 13.03B | 12.41B | 12.46B | 12.68B |
| Long-term Investments | 8.74B | 8.95B | 8.80B | 8.81B | 8.68B |
| Goodwill | 8.74B | 8.95B | 8.80B | 8.81B | 8.68B |
| Total Other Intangibles | 19.42B | 20.12B | 19.55B | 19.79B | 18.81B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 10.85B | 11.03B | 9.98B | 9.49B | 9.69B |
| Total Assets | 74.44B | 77.80B | 73.38B | 73.90B | 75.16B |
|
|
|||||
| Total Accounts Payable | 4.33B | 18.06B | 16.84B | 17.31B | 4.74B |
| Total Accrued Expenses | 5.08B | -- | -- | -- | 4.98B |
| Short-term Debt | -- | 219.81M | 104.89M | 255.12M | 1.04B |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.94B | 3.55B | 4.15B | 3.05B | 2.54B |
| Total Finance Division Other Current Liabilities | 14.81B | 6.93B | 4.62B | 4.45B | 13.53B |
| Total Other Current Liabilities | 14.81B | 6.93B | 4.62B | 4.45B | 13.53B |
| Total Current Liabilities | 27.16B | 28.76B | 25.71B | 25.07B | 26.84B |
|
|
|||||
| Total Current Liabilities | 27.16B | 28.76B | 25.71B | 25.07B | 26.84B |
| Long-Term Debt | 17.16B | 17.75B | 17.16B | 19.14B | 18.03B |
| Short-term Debt | -- | 219.81M | 104.89M | 255.12M | 1.04B |
| Capital Leases | 1.17B | -- | -- | -- | 1.34B |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 12.57B | 13.26B | 13.11B | 12.98B | 12.66B |
| Total Liabilities | 58.06B | 59.77B | 55.98B | 57.19B | 58.86B |
|
|
|||||
| Common Stock & APIC | 6.04B | 6.46B | 6.09B | 6.09B | 6.11B |
| Retained Earnings | 10.98B | 10.97B | 10.85B | 10.02B | 9.86B |
| Treasury Stock & Other | 103.91M | 1.34B | 1.22B | 1.37B | 1.03B |
| Total Common Equity | 17.12B | 18.77B | 18.16B | 17.48B | 17.00B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 17.12B | 18.77B | 18.16B | 17.48B | 17.00B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -732.38M | -743.87M | -760.80M | -771.68M | -703.11M |
| Total Equity | 16.38B | 18.03B | 17.40B | 16.71B | 16.30B |
|
|
|||||
